[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369776-105":59,"doc-detail-369776-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mutational-analysis-of-early-low-grade-bowel-polyps-defines-a-subgroup-with-concurrent-high-risk-oncogenic-drivers-independent-of-polyp-size","Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size","","Accumulation of pathogenic mutations in premalignant colorectal lesions drives cancer development, yet the frequency and diversity of driver mutations in early-stage polyps remain insufficiently defined. Whole-exome sequencing of low-grade dysplasia (LGD) colorectal polyps and matched germline DNA shows no link between mutational burden and polyp size (3–15 mm). However, a subset carries concurrent oncogenic alterations in WNT/β-catenin, p53, or RTK-RAS pathways. Immune effector programs, including NF-κB signaling, typify these cases, implying enhanced oncogenic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mutational-analysis-of-early-low-grade-bowel-polyps-defines-a-subgroup-with-concurrent-high-risk-oncogenic-drivers-independent-of-polyp-size/369776/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mutational-analysis-of-early-low-grade-bowel-polyps-defines-a-subgroup-with-concurrent-high-risk-oncogenic-drivers-independent-of-polyp-size/369776.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How did the study investigate early, low-grade colorectal polyps?","Question",{"text":112,"@type":113},"The researchers used whole-exome sequencing of low-grade dysplasia (LGD) colorectal polyps and paired germline DNA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Is polyp size linked to mutational burden in early LGD lesions?",{"text":117,"@type":113},"No. The study reports no association between mutational burden and polyp size across 3–15 mm.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular features characterize a subgroup of LGD polyps with higher oncogenic potential?",{"text":121,"@type":113},"A subset harbored concurrent oncogenic alterations in cancer-causing pathways including WNT/β-catenin, p53, or RTK-RAS, alongside immune effector signatures such as NF-κB signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369776,1790297503,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-25-0182](https://doi.org/10.1158/2767-9764.CRC-25-0182)  OPEN ACCESS  \nMutational Analysis of Early, Low-Grade Bowel  Polyps Defines a Subgroup with Concurrent,  \nHigh-Risk Oncogenic Drivers Independent of Polyp Size  \nJun Li1, Zoe Welham1, Benita Tse1, Chahaya Gauci2,3, Shila Ghazanfar4, Pratibha Panwar4, Alexander Engel2,3, and Mark P. Molloy1  \n􀀶  \nABSTRACT  \nThe accumulation of pathogenic mutations in premalignant colorectal neoplasms is critical for colorectal cancer development; however, the frequency and diversity of pathogenic driver mutations in early-stage colorectal polyps is incompletely known. We investigated this by wholeexome sequencing of low-grade dysplasia (LGD) colorectal polyps and paired germline DNA. Interestingly, in these early lesions, there was no association with mutational burden and the known risk factor of polyp size (range, 3–15 mm) . However, a subset of LGD polyps harbored concurrent, oncogenic alterations in colorectal cancer–causing pathways ofWNT/β-catenin, p53, or RTK-RAS. Further analysis suggested that the concurrent mutation signature was associated with increased polyp burden. Spatial transcriptomic analysis revealed that immune effectors,  \nincluding NF-κB signaling, were a characteristic of LGD polyps with concurrent pathogenic mutations. Together, these observations suggest that some small-sized, early colorectal neoplasms have enhanced oncogenic potential and highlight that nonadvanced colorectal adenoma may not be universally considered a low-risk finding.  \nSignificance: Through whole-exome sequencing of early colorectal polyps characterized by LGD, we demonstrate that polyp size poorly correlates with mutational burden. Some small-sized (\u003C10 mm polyps) early polyps harbored concurrent driver gene mutations commonly seen in adenocarcinoma. Sequencing of key driver genes in early polyps may identify risky lesions that cannot be detected by histology alone.  \nIntroduction  \nColorectal cancer maintains a high worldwide disease burden as the third most common malignancy and the second leading cause of cancer mortality ( 1) . Colonoscopy with subsequent excision of bowel polyps has been proven as an effective intervention to reduce colorectal cancer incidence and mortality (2, 3) . Based on clinical guidelines, risk assessment for metachronous adenomas and neoplasia after removal of colonic polyps may depend on the size, histology, and number of polyps detected and removed (4) . High-risk factors are polyp size of ≥10 mm that confers a 3% annual risk for colorectal  \n1Bowel Cancer and Biomarker Laboratory, Kolling Institute, School of Medical Sciences, The University of Sydney, Sydney, Australia. 2Colorectal Surgical Unit, Royal North Shore Hospital, St. Leonards, Australia. 3Sydney Medical School, The University of Sydney, Sydney, Australia. 4School of Mathematics and Statistics, The University of Sydney, Sydney, Australia.  \nA. Engel and M. P. Molloy are co senior authors of this article.  \nCorresponding Author: Mark P. Molloy, Kolling Institute, Westbourne Street, St.  \nLeonards 2065, [Australia. E-mail:](Australia. E-mail: m.molloy@sydney.edu.au)[ m.molloy@sydney.edu.au](Australia. E-mail: m.molloy@sydney.edu.au)[ ](Australia. E-mail: m.molloy@sydney.edu.au)[doi:](doi: 10.1158/2767-9764)[ 10.1158/2767-9764](doi: 10.1158/2767-9764) .CRC-25-0182  \nThis open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.  \n©2025 The Authors; Published by the American Association for Cancer Research  \ncancer development, villous architecture that confers a risk of 17%, or highgrade dysplasia that already has a risk of 37%(5–7) . Despite the well-known benefits of screening, the accuracy of pathologic risk factors for informing the timing of surveillance colonoscopy is debated (8), leading to variability in guidelines according to jurisdictions (4) .  \nAdenomas and carcinomas are infrequ","cbCaihY3LV1fSKEw","https://ap.wps.com/l/cbCaihY3LV1fSKEw","pdf",2829453,12,"English","# ABSTRACT\n# Significance\n# Introduction","[{\"question\":\"How did the study investigate early, low-grade colorectal polyps?\",\"answer\":\"The researchers used whole-exome sequencing of low-grade dysplasia (LGD) colorectal polyps and paired germline DNA.\"},{\"question\":\"Is polyp size linked to mutational burden in early LGD lesions?\",\"answer\":\"No. The study reports no association between mutational burden and polyp size across 3–15 mm.\"},{\"question\":\"What molecular features characterize a subgroup of LGD polyps with higher oncogenic potential?\",\"answer\":\"A subset harbored concurrent oncogenic alterations in cancer-causing pathways including WNT/β-catenin, p53, or RTK-RAS, alongside immune effector signatures such as NF-κB signaling.\"}]","Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size | PDF",1790184492,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99f9815bc5e955947c5e0889d7d3c753.webp",983,1263,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/677c5752c2423df5c4a76f413a392f28.webp",982,1262,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd85d2f8dbcf1bc6e45301bbbe319366.webp",981,1261,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2444829318362d43cb3bea6747690094.webp",980,1259]